DXP Enterprises Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
DXP Enterprises Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-09-30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | |||||||||||||||||||||||||||||||||||
net income | 23,612,000 | 20,589,000 | 21,363,000 | 21,101,000 | 16,693,000 | 11,332,000 | 16,006,000 | 16,172,000 | 19,054,000 | 17,580,000 | 8,037,000 | 13,044,000 | 14,492,000 | 12,529,000 | 726,000 | 6,936,000 | 7,961,000 | 128,000 | -2,027,000 | -34,775,000 | 2,080,000 | 5,648,000 | 2,088,000 | 13,150,000 | 13,350,000 | 7,187,000 | 11,102,000 | -3,204,000 | -52,684,000 | 7,167,000 | 9,651,000 | 17,643,000 | 15,539,000 | 11,618,000 | 16,352,000 |
reconciliation of net income to net cash from operating activities: | |||||||||||||||||||||||||||||||||||
depreciation | 2,520,000 | 2,316,000 | 2,198,000 | 2,365,000 | 2,248,000 | 2,208,000 | 2,161,000 | 2,117,000 | 2,121,000 | 2,024,000 | 2,218,000 | 2,361,000 | 2,489,000 | 2,517,000 | 2,566,000 | 2,248,000 | 2,652,000 | 2,480,000 | 2,398,000 | 2,251,000 | 2,919,000 | 2,828,000 | 2,830,000 | 2,616,000 | 2,262,000 | 2,392,000 | 2,443,000 | 3,614,000 | 3,089,000 | 3,018,000 | 2,901,000 | 3,342,000 | 3,093,000 | 2,984,000 | 2,229,000 |
amortization of intangibles and finance lease assets | |||||||||||||||||||||||||||||||||||
amortization of debt issuance costs | 962,000 | 965,000 | 968,000 | 890,000 | 893,000 | 895,000 | 441,000 | 458,000 | 458,000 | 302,000 | 402,000 | 427,000 | 427,000 | 469,000 | 469,000 | 469,000 | 468,000 | 469,000 | 470,000 | 468,000 | 468,000 | 406,000 | 330,000 | 303,000 | 289,000 | 289,000 | |||||||||
gain on sale of property and equipment | -7,000 | -325,000 | -36,000 | 0 | 0 | -246,000 | 0 | -1,000 | 0 | -8,000 | |||||||||||||||||||||||||
recovery of credit losses | 237,000 | -1,322,000 | |||||||||||||||||||||||||||||||||
payment of contingent consideration liability in excess of acquisition-date fair value | 0 | -91,000 | 0 | -17,000 | 0 | -81,000 | 0 | 100,000 | 0 | 0 | 0 | 0 | 0 | 0 | -106,000 | ||||||||||||||||||||
fair value adjustment on contingent consideration | 545,000 | 183,000 | 365,000 | 685,000 | -111,000 | -194,000 | 236,000 | 663,000 | 497,000 | 342,000 | 186,000 | 436,000 | 1,158,000 | 531,000 | -408,000 | -26,000 | 26,000 | 13,000 | -47,000 | 35,000 | 33,000 | 33,000 | |||||||||||||
restricted stock compensation expense | 1,483,000 | 1,317,000 | 1,316,000 | 1,322,000 | 1,212,000 | 864,000 | 861,000 | 864,000 | 871,000 | 476,000 | 505,000 | 493,000 | 370,000 | ||||||||||||||||||||||
deferred income taxes | 3,093,000 | 3,943,000 | -4,614,000 | -5,432,000 | -1,888,000 | -3,056,000 | 1,119,000 | -3,865,000 | -3,514,000 | -2,799,000 | -4,532,000 | -4,619,000 | 1,199,000 | 411,000 | -571,000 | 5,643,000 | 609,000 | 459,000 | -8,294,000 | -6,651,000 | -754,000 | 928,000 | -1,227,000 | 1,411,000 | 204,000 | 722,000 | 764,000 | -920,000 | -8,117,000 | -1,249,000 | 1,262,000 | 2,571,000 | 1,583,000 | -2,804,000 | -511,000 |
other non-cash items | 1,101,000 | -6,100,000 | |||||||||||||||||||||||||||||||||
changes in operating assets and liabilities, net of effects of businesses acquired: | |||||||||||||||||||||||||||||||||||
accounts receivable | -2,770,000 | -13,202,000 | -227,000 | -9,240,000 | -12,078,000 | 8,993,000 | 10,998,000 | ||||||||||||||||||||||||||||
costs and estimated profits in excess of billings | -9,336,000 | 2,893,000 | -12,953,000 | -1,491,000 | 7,052,000 | -478,000 | 4,052,000 | 3,133,000 | 8,844,000 | 5,413,000 | -3,381,000 | 1,463,000 | 1,582,000 | 2,675,000 | -5,628,000 | 5,901,000 | |||||||||||||||||||
inventories | -811,000 | -3,525,000 | 7,302,000 | -1,418,000 | 1,794,000 | 754,000 | 1,371,000 | -218,000 | 4,827,000 | -8,006,000 | -6,310,000 | 17,675,000 | 5,468,000 | 1,280,000 | -2,215,000 | 2,592,000 | -3,925,000 | -6,223,000 | -6,891,000 | 1,630,000 | 4,166,000 | 2,489,000 | 3,051,000 | 3,018,000 | -5,431,000 | 1,591,000 | 1,041,000 | 199,000 | |||||||
prepaid expenses and other assets | -881,000 | -2,369,000 | 4,807,000 | 581,000 | -1,099,000 | 3,366,000 | -6,917,000 | 11,357,000 | -3,618,000 | 8,844,000 | -7,293,000 | 8,063,000 | 2,404,000 | 4,519,000 | -1,933,000 | 3,324,000 | -5,509,000 | 3,906,000 | 3,389,000 | 438,000 | 1,548,000 | 1,775,000 | -983,000 | -2,181,000 | 486,000 | -2,928,000 | 925,000 | -469,000 | |||||||
trade accounts payable | |||||||||||||||||||||||||||||||||||
accrued expenses | 7,244,000 | -3,569,000 | |||||||||||||||||||||||||||||||||
billings in excess of costs and estimated profits | 3,059,000 | 6,764,000 | 853,000 | -181,000 | 3,892,000 | -1,301,000 | 2,316,000 | 1,863,000 | 1,884,000 | 594,000 | -969,000 | -7,327,000 | 1,250,000 | -2,260,000 | -2,514,000 | ||||||||||||||||||||
income taxes | -8,378,000 | -18,908,000 | |||||||||||||||||||||||||||||||||
net cash from operating activities | 18,646,000 | 2,973,000 | 32,143,000 | 28,344,000 | 14,735,000 | 26,989,000 | 42,447,000 | 39,758,000 | -2,432,000 | 26,449,000 | 3,638,000 | -3,430,000 | 3,006,000 | 2,680,000 | 14,258,000 | 6,625,000 | 5,654,000 | 10,552,000 | 15,435,000 | 30,476,000 | 63,376,000 | -1,612,000 | 33,822,000 | 10,945,000 | 1,850,000 | -5,310,000 | 25,998,000 | 23,186,000 | 20,999,000 | 31,823,000 | 21,981,000 | 43,106,000 | -883,000 | 20,650,000 | 28,650,000 |
capex | -10,346,000 | -19,914,000 | -9,395,000 | -3,954,000 | -8,825,000 | -2,894,000 | -5,160,000 | -1,486,000 | -1,813,000 | -3,804,000 | -1,490,000 | -1,578,000 | -1,108,000 | -740,000 | -3,015,000 | -1,458,000 | -846,000 | -680,000 | -142,000 | -1,397,000 | -1,898,000 | -3,235,000 | -7,873,000 | -5,663,000 | -6,272,000 | -2,312,000 | -1,618,000 | -2,273,000 | -5,203,000 | -2,942,000 | -3,574,000 | -3,372,000 | -3,016,000 | -1,684,000 | -1,884,000 |
free cash flows | 8,300,000 | -16,941,000 | 22,748,000 | 24,390,000 | 5,910,000 | 24,095,000 | 37,287,000 | 38,272,000 | -4,245,000 | 22,645,000 | 2,148,000 | -5,008,000 | 1,898,000 | 1,940,000 | 11,243,000 | 5,167,000 | 4,808,000 | 9,872,000 | 15,293,000 | 29,079,000 | 61,478,000 | -4,847,000 | 25,949,000 | 5,282,000 | -4,422,000 | -7,622,000 | 24,380,000 | 20,913,000 | 15,796,000 | 28,881,000 | 18,407,000 | 39,734,000 | -3,899,000 | 18,966,000 | 26,766,000 |
cash flows from investing activities: | |||||||||||||||||||||||||||||||||||
purchase of property and equipment | -10,346,000 | -19,914,000 | -9,395,000 | -3,954,000 | -8,825,000 | -2,894,000 | -5,160,000 | -1,486,000 | -1,813,000 | -3,804,000 | -1,490,000 | -1,578,000 | -1,108,000 | -740,000 | -3,015,000 | -1,458,000 | -846,000 | -680,000 | -142,000 | -1,397,000 | -1,898,000 | -3,235,000 | -7,873,000 | -5,663,000 | -6,272,000 | -2,312,000 | -1,618,000 | -2,273,000 | -5,203,000 | -2,942,000 | -3,574,000 | -3,372,000 | -3,016,000 | -1,684,000 | -1,884,000 |
proceeds from the sale of property and equipment | 16,000 | 2,699,000 | 372,000 | 0 | 0 | 1,297,000 | 0 | 0 | 0 | 1,000 | 5,000 | 29,000 | |||||||||||||||||||||||
acquisition of businesses, net of cash acquired | -1,010,000 | -12,850,000 | -7,184,000 | -30,423,000 | -79,756,000 | -39,261,000 | -1,536,000 | -360,000 | |||||||||||||||||||||||||||
net cash from investing activities | -11,340,000 | -30,065,000 | -16,579,000 | -34,377,000 | -88,581,000 | -42,155,000 | -6,696,000 | -1,846,000 | -10,301,000 | -3,804,000 | -1,490,000 | -5,967,000 | -39,909,000 | -6,056,000 | -2,726,000 | -21,633,000 | -45,281,000 | 617,000 | -101,271,000 | -1,362,000 | -1,775,000 | -17,388,000 | -7,873,000 | -5,662,000 | -6,267,000 | -2,283,000 | -1,605,000 | -2,273,000 | -15,704,000 | -7,942,000 | -3,574,000 | -3,121,000 | -13,694,000 | -290,415,000 | -21,721,000 |
cash flows from financing activities: | |||||||||||||||||||||||||||||||||||
principal debt payments | -1,624,000 | -1,624,000 | -1,092,000 | -1,092,000 | -825,000 | -825,000 | -825,000 | -825,000 | -825,000 | -825,000 | -825,000 | -217,500,000 | -10,625,000 | -15,625,000 | -625,000 | -625,000 | -2,016,000 | -851,000 | -849,000 | -847,000 | |||||||||||||||
debt issuance costs | 0 | -125,000 | -7,858,000 | -7,130,000 | 0 | ||||||||||||||||||||||||||||||
shares repurchased held in treasury | -224,000 | -4,805,000 | -9,163,000 | -14,815,000 | 0 | -22,632,000 | |||||||||||||||||||||||||||||
payment for acquisition contingent consideration liability | -1,325,000 | -3,820,000 | -420,000 | -97,000 | -3,500,000 | -983,000 | -583,000 | -1,169,000 | |||||||||||||||||||||||||||
preferred stock dividends paid | -22,000 | -23,000 | -22,000 | -23,000 | -22,000 | -23,000 | -22,000 | -22,000 | -23,000 | -22,000 | -22,000 | -23,000 | |||||||||||||||||||||||
payment for employee taxes withheld from stock awards | -4,204,000 | -126,000 | -8,000 | -63,000 | -1,701,000 | -54,000 | -63,000 | -32,000 | -328,000 | -104,000 | 0 | -2,000 | -131,000 | -159,000 | 0 | -52,000 | -68,000 | -517,000 | 0 | -23,000 | -22,000 | -94,000 | -1,000 | -138,000 | -84,000 | -44,000 | -8,000 | ||||||||
principal payments on finance leases | -2,336,000 | -1,365,000 | -1,206,000 | -1,018,000 | -1,096,000 | -896,000 | |||||||||||||||||||||||||||||
net cash from financing activities | -9,511,000 | -7,083,000 | 99,187,000 | -7,381,000 | -16,857,000 | -18,146,000 | 110,323,000 | -26,579,000 | -29,811,000 | -10,354,000 | 26,019,000 | 6,270,000 | 21,345,000 | -9,322,000 | -25,589,000 | -900,000 | -10,639,000 | -1,365,000 | 105,348,000 | -10,809,000 | -16,391,000 | -742,000 | -648,000 | -2,177,000 | -957,000 | -2,310,000 | 73,000 | -27,110,000 | 936,000 | -25,308,000 | -15,642,000 | -42,181,000 | 14,606,000 | 276,599,000 | -10,956,000 |
effect of foreign currency on cash | 852,000 | 47,000 | -1,431,000 | -1,521,000 | 941,000 | -111,000 | -130,000 | 310,000 | -205,000 | -35,000 | 887,000 | -475,000 | -427,000 | 268,000 | 3,000 | -218,000 | 99,000 | 204,000 | 553,000 | 304,000 | 705,000 | -1,730,000 | 463,000 | -98,000 | 199,000 | 112,000 | -337,000 | -247,000 | 418,000 | 506,000 | -403,000 | 26,000 | -67,000 | -172,000 | 204,000 |
net change in cash and restricted cash | -1,353,000 | -34,128,000 | 113,320,000 | -14,935,000 | -89,762,000 | -33,423,000 | 145,944,000 | 11,643,000 | -42,749,000 | 12,256,000 | -3,602,000 | -15,985,000 | -12,430,000 | -16,126,000 | -50,167,000 | 10,008,000 | 18,609,000 | 45,915,000 | -21,472,000 | 3,008,000 | -5,175,000 | -9,791,000 | |||||||||||||
cash and restricted cash at beginning of period | 0 | 148,411,000 | 0 | 0 | 173,211,000 | 0 | 0 | 46,117,000 | 0 | 0 | 49,080,000 | 0 | 1,975,000 | 117,444,000 | 0 | 0 | 54,326,000 | 0 | 0 | 40,519,000 | |||||||||||||||
cash and restricted cash at end of period | -1,353,000 | 114,283,000 | -14,935,000 | -89,762,000 | 139,788,000 | 11,643,000 | -42,749,000 | 58,373,000 | -3,602,000 | -15,985,000 | 36,650,000 | -16,126,000 | -48,192,000 | 127,452,000 | 18,609,000 | 45,915,000 | 32,854,000 | 3,008,000 | -5,175,000 | 30,728,000 | |||||||||||||||
supplemental cash flow information | |||||||||||||||||||||||||||||||||||
balance at december 31, 2024 | 0 | 1,000 | |||||||||||||||||||||||||||||||||
preferred dividends paid | |||||||||||||||||||||||||||||||||||
compensation expense for restricted stock | 669,000 | 747,000 | 745,000 | 812,000 | 922,000 | 1,047,000 | 685,000 | 710,000 | |||||||||||||||||||||||||||
tax related items for share based awards | |||||||||||||||||||||||||||||||||||
currency translation adjustment | |||||||||||||||||||||||||||||||||||
excise tax on share repurchases | |||||||||||||||||||||||||||||||||||
balance at march 31, 2025 | 0 | 1,000 | |||||||||||||||||||||||||||||||||
balance at june 30, 2025 | |||||||||||||||||||||||||||||||||||
amortization of intangibles and fixed assets | 6,818,000 | 6,822,000 | 6,355,000 | 5,879,000 | 5,330,000 | ||||||||||||||||||||||||||||||
accounts payable | 6,505,000 | ||||||||||||||||||||||||||||||||||
(recovery of) benefit from credit losses | -104,000 | -12,000 | 429,000 | -1,200,000 | |||||||||||||||||||||||||||||||
loss on debt extinguishment | |||||||||||||||||||||||||||||||||||
loss on sale of interest in vie | |||||||||||||||||||||||||||||||||||
cost and estimated profits in excess of billings | |||||||||||||||||||||||||||||||||||
accounts payable and accrued expenses | -9,075,000 | 19,640,000 | -853,000 | -2,165,000 | -2,264,000 | 11,147,000 | -11,590,000 | 13,311,000 | -21,127,000 | -1,859,000 | -2,302,000 | -18,389,000 | 8,671,000 | -2,752,000 | 10,449,000 | 13,339,000 | |||||||||||||||||||
other long-term liabilities | 789,000 | 4,732,000 | -785,000 | -5,872,000 | 3,767,000 | -3,618,000 | 3,257,000 | -2,379,000 | -1,827,000 | -3,029,000 | -1,635,000 | -697,000 | 2,825,000 | -4,065,000 | -4,781,000 | -1,000 | |||||||||||||||||||
borrowings on asset-backed credit facility | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||
repayments on asset-backed credit facility | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||
proceeds from debt | 83,261,000 | 103,804,000 | 83,135,000 | 123,351,000 | 105,113,000 | 161,349,000 | 380,439,000 | 120,726,000 | |||||||||||||||||||||||||||
cash and restricted cash at beginning of year | |||||||||||||||||||||||||||||||||||
cash and restricted cash at end of year | |||||||||||||||||||||||||||||||||||
series a preferred stock | |||||||||||||||||||||||||||||||||||
balance at december 31, 2021 | 1,000 | ||||||||||||||||||||||||||||||||||
issuance of shares of common stock | |||||||||||||||||||||||||||||||||||
repurchases of shares | |||||||||||||||||||||||||||||||||||
balance at december 31, 2022 | 0 | ||||||||||||||||||||||||||||||||||
balance at december 31, 2023 | 0 | 0 | 1,000 | ||||||||||||||||||||||||||||||||
other | -20,291,000 | ||||||||||||||||||||||||||||||||||
repayments under term loan facility | -1,375,000 | -1,375,000 | -1,375,000 | -1,092,000 | |||||||||||||||||||||||||||||||
balance at march 31, 2024 | 0 | 0 | 1,000 | ||||||||||||||||||||||||||||||||
balance at june 30, 2024 | 0 | ||||||||||||||||||||||||||||||||||
balance at september 30, 2024 | |||||||||||||||||||||||||||||||||||
amortization of intangible assets and fixed assets | |||||||||||||||||||||||||||||||||||
amortization of deferred financing costs | |||||||||||||||||||||||||||||||||||
changes in operating assets and liabilities, and other: | |||||||||||||||||||||||||||||||||||
principal repayments on finance lease obligations | |||||||||||||||||||||||||||||||||||
balance at december 31, 2020 | 1,000 | ||||||||||||||||||||||||||||||||||
stock compensation expense | 469,000 | 514,000 | 460,000 | 380,000 | 662,000 | 983,000 | 983,000 | 904,000 | 461,000 | 473,000 | 524,000 | 505,000 | 526,000 | ||||||||||||||||||||||
benefit from (recovery of) credit losses | |||||||||||||||||||||||||||||||||||
changes in operating assets and liabilities: | |||||||||||||||||||||||||||||||||||
balance at march 31, 2023 | 0 | ||||||||||||||||||||||||||||||||||
balance at june 30, 2023 | 0 | ||||||||||||||||||||||||||||||||||
balance at september 30, 2023 | |||||||||||||||||||||||||||||||||||
amortization of intangible assets and deferred financing costs | 5,349,000 | 5,400,000 | |||||||||||||||||||||||||||||||||
benefit from credit losses | 503,000 | 498,000 | 520,000 | 461,000 | -147,000 | 276,000 | 45,000 | -682,000 | |||||||||||||||||||||||||||
accounts receivables | |||||||||||||||||||||||||||||||||||
supplemental schedule of non-cash investing and financing activities: | |||||||||||||||||||||||||||||||||||
shares issued for acquisitions | 0 | 1,013,000 | 4,217,000 | 527,000 | |||||||||||||||||||||||||||||||
changes in accounts receivables | 9,070,000 | ||||||||||||||||||||||||||||||||||
acquisition of business, net of cash acquired | -4,389,000 | -38,801,000 | -5,316,000 | -20,175,000 | 35,000 | 0 | -14,153,000 | ||||||||||||||||||||||||||||
purchase of treasury stock | -9,135,000 | -29,402,000 | -3,354,000 | -6,801,000 | -8,315,000 | -24,742,000 | 0 | 0 | 0 | 0 | -8,908,000 | 0 | 0 | ||||||||||||||||||||||
balance at march 31, 2022 | 1,000 | ||||||||||||||||||||||||||||||||||
impairment and other charges | 11,482,000 | ||||||||||||||||||||||||||||||||||
bad debt expense | 406,000 | 354,000 | 406,000 | 28,000 | 214,000 | 153,000 | -286,000 | 58,000 | -265,000 | 712,000 | 385,000 | 401,000 | 516,000 | ||||||||||||||||||||||
loss on extinguishment and modification of debt | |||||||||||||||||||||||||||||||||||
change in accounts receivable | |||||||||||||||||||||||||||||||||||
proceeds from revolving credit facilities | 221,895,000 | 369,288,000 | |||||||||||||||||||||||||||||||||
payments on revolving credit facilities | -262,501,000 | -357,806,000 | |||||||||||||||||||||||||||||||||
issuance of common stock- shares sold in public market | |||||||||||||||||||||||||||||||||||
payment for contingent consideration liability | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||
net change in cash | 24,129,000 | ||||||||||||||||||||||||||||||||||
supplemental cash flow information: | |||||||||||||||||||||||||||||||||||
cash paid for interest | |||||||||||||||||||||||||||||||||||
cash paid for income taxes | |||||||||||||||||||||||||||||||||||
share repurchase agreement | 0 | ||||||||||||||||||||||||||||||||||
amortization of intangible assets | 5,132,000 | 4,591,000 | 4,235,000 | 4,507,000 | 4,238,000 | 4,306,000 | 4,146,000 | 2,991,000 | 3,053,000 | 3,046,000 | 3,197,000 | 3,651,000 | 3,806,000 | 3,803,000 | 3,814,000 | 4,011,000 | 4,714,000 | 5,240,000 | 5,309,000 | 5,358,000 | 4,651,000 | 4,653,000 | 4,570,000 | 3,434,000 | |||||||||||
net change in all other operating assets and liabilities | |||||||||||||||||||||||||||||||||||
payment for contingent consideration liability up to acquisition-date fair value | -1,394,000 | ||||||||||||||||||||||||||||||||||
balance at june 30, 2021 | 0 | ||||||||||||||||||||||||||||||||||
balance at september 30, 2021 | |||||||||||||||||||||||||||||||||||
net change in operating assets and liabilities | -22,335,000 | -18,224,000 | -13,632,000 | ||||||||||||||||||||||||||||||||
balance at march 31, 2021 | 0 | 1,000 | |||||||||||||||||||||||||||||||||
issuance of common stock | |||||||||||||||||||||||||||||||||||
reconciliation of net income to net cash provided (used in) by operating activities: | |||||||||||||||||||||||||||||||||||
net income attributable to dxp enterprises, inc. | 881,000 | 7,125,000 | 8,150,000 | 340,000 | -1,912,000 | -34,666,000 | 2,142,000 | 5,710,000 | 2,176,000 | 13,109,000 | 13,459,000 | 7,291,000 | 11,122,000 | -2,919,000 | |||||||||||||||||||||
less: net income attributable to non-controlling interest | -155,000 | -189,000 | -189,000 | -212,000 | -115,000 | -109,000 | -62,000 | -62,000 | -88,000 | 41,000 | |||||||||||||||||||||||||
changes in operating assets and liabilities | |||||||||||||||||||||||||||||||||||
trade accounts receivable | -2,245,000 | 5,697,000 | 2,796,000 | 39,599,000 | -5,183,000 | 23,141,000 | -179,000 | -12,367,000 | -5,035,000 | -9,262,000 | 23,049,000 | 6,580,000 | 18,044,000 | 23,588,000 | 10,275,000 | -22,604,000 | -8,181,000 | -6,601,000 | |||||||||||||||||
billings in excess of costs & estimated profits | |||||||||||||||||||||||||||||||||||
balances at december 31, 2018 | |||||||||||||||||||||||||||||||||||
dividends paid | -23,000 | -22,000 | -23,000 | -23,000 | -22,000 | -23,000 | -23,000 | -22,000 | -23,000 | -23,000 | -22,000 | -23,000 | -23,000 | -22,000 | -23,000 | -23,000 | |||||||||||||||||||
cumulative translation adjustment | |||||||||||||||||||||||||||||||||||
balance at december 31, 2019 | 1,000 | ||||||||||||||||||||||||||||||||||
issuance of shares of common stock-acquisition | |||||||||||||||||||||||||||||||||||
issuance of shares of common stock-shares sold in public market | |||||||||||||||||||||||||||||||||||
balance at june 30, 2020 | 0 | ||||||||||||||||||||||||||||||||||
balance at september 30, 2020 | |||||||||||||||||||||||||||||||||||
shares issued for the acquisition of cvi | |||||||||||||||||||||||||||||||||||
balance at march 31, 2020 | 0 | 1,000 | |||||||||||||||||||||||||||||||||
issuance of common stock sold in public markets, net of commissions and fees | |||||||||||||||||||||||||||||||||||
trade accounts payable and accrued expenses | 10,115,000 | -1,862,000 | 7,524,000 | 6,048,000 | -7,212,000 | -174,000 | 1,085,000 | ||||||||||||||||||||||||||||
acquisition of businesses | |||||||||||||||||||||||||||||||||||
non-controlling interest holder contributions (distributions), net of tax benefits | |||||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash at beginning of year | |||||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash at end of year | |||||||||||||||||||||||||||||||||||
issuance of common stock sold in public market | 0 | ||||||||||||||||||||||||||||||||||
balance at june 30, 2019 | 0 | ||||||||||||||||||||||||||||||||||
balance at september 30, 2019 | |||||||||||||||||||||||||||||||||||
balance at march 31, 2019 | 0 | 1,000 | |||||||||||||||||||||||||||||||||
balance at december 31, 2018 | 1,000 | ||||||||||||||||||||||||||||||||||
write off of debt issuance costs | |||||||||||||||||||||||||||||||||||
acquisition of business | |||||||||||||||||||||||||||||||||||
cash at beginning of year | |||||||||||||||||||||||||||||||||||
cash at end of year | |||||||||||||||||||||||||||||||||||
balances at december 31, 2016 | |||||||||||||||||||||||||||||||||||
balances at december 31, 2017 | 1,000 | ||||||||||||||||||||||||||||||||||
non-controlling interest holder contributions, net of tax benefits | |||||||||||||||||||||||||||||||||||
balances at december 31, 2019 | |||||||||||||||||||||||||||||||||||
write-off of debt issuance costs | |||||||||||||||||||||||||||||||||||
balances at june 30, 2018 | 0 | ||||||||||||||||||||||||||||||||||
balances at september 30, 2018 | |||||||||||||||||||||||||||||||||||
balances at march 31, 2018 | 0 | 1,000 | |||||||||||||||||||||||||||||||||
less net income attributable to non-controlling interest | -104,000 | ||||||||||||||||||||||||||||||||||
reconciliation of net income to the net cash from operating activities: | |||||||||||||||||||||||||||||||||||
gain on sale of subsidiary | |||||||||||||||||||||||||||||||||||
tax loss related to vesting of restricted stock | |||||||||||||||||||||||||||||||||||
proceeds from sale of subsidiary | |||||||||||||||||||||||||||||||||||
proceeds from issuance of common shares | |||||||||||||||||||||||||||||||||||
tax (loss) related to vesting of restricted stock | |||||||||||||||||||||||||||||||||||
balances at january 1, 2016 | |||||||||||||||||||||||||||||||||||
issuance of 2,722,858 shares of common stock | |||||||||||||||||||||||||||||||||||
issuance of 264,297 shares of treasury stock | |||||||||||||||||||||||||||||||||||
gain on sale of building | |||||||||||||||||||||||||||||||||||
proceeds from the sale of fixed assets | |||||||||||||||||||||||||||||||||||
loss for non-controlling interest owners, net of tax | |||||||||||||||||||||||||||||||||||
cash at beginning of period | |||||||||||||||||||||||||||||||||||
cash at end of period | |||||||||||||||||||||||||||||||||||
fair value measurements using significant unobservable inputs | |||||||||||||||||||||||||||||||||||
beginning balance at january 1, 2018 | |||||||||||||||||||||||||||||||||||
acquisitions and settlements | |||||||||||||||||||||||||||||||||||
acquisition of asi | |||||||||||||||||||||||||||||||||||
settlements | |||||||||||||||||||||||||||||||||||
total remeasurement adjustments: | |||||||||||||||||||||||||||||||||||
(gains) or losses recorded against goodwill | |||||||||||||||||||||||||||||||||||
changes in fair value recorded in profit and loss | |||||||||||||||||||||||||||||||||||
ending balance at september 30, 2018 | |||||||||||||||||||||||||||||||||||
the amount of total (gains) or losses for the year included in earnings or changes to net assets, attributable to changes in unrealized (gains) or losses relating to assets or liabilities still held at year-end. | |||||||||||||||||||||||||||||||||||
* included in other current and long-term liabilities | |||||||||||||||||||||||||||||||||||
less net income attributable to noncontrolling interest | |||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||||||||||||||||
impairment of goodwill | |||||||||||||||||||||||||||||||||||
gain on reversal of earn-out | |||||||||||||||||||||||||||||||||||
tax benefit related to vesting of restricted stock | -46,000 | -24,000 | -105,000 | -637,000 | -32,000 | ||||||||||||||||||||||||||||||
changes in operating assets and liabilities, net of assets and liabilities acquired in business acquisitions: | |||||||||||||||||||||||||||||||||||
cost in excess of billings on uncompleted contracts | |||||||||||||||||||||||||||||||||||
billings in excess of costs on uncompleted contracts | |||||||||||||||||||||||||||||||||||
sale of investments | |||||||||||||||||||||||||||||||||||
acquisitions of businesses, net of cash acquired | 0 | -10,501,000 | 251,000 | -14,054,000 | -287,043,000 | -19,837,000 | |||||||||||||||||||||||||||||
principal payments on revolving line of credit and other long-term debt | -110,234,000 | -104,773,000 | -108,457,000 | -130,016,000 | -147,295,000 | -140,055,000 | -104,454,000 | -131,691,000 | |||||||||||||||||||||||||||
debt issuance fees | 0 | ||||||||||||||||||||||||||||||||||
contributions from noncontrolling interest holders, net of losses | |||||||||||||||||||||||||||||||||||
increase in cash | |||||||||||||||||||||||||||||||||||
balance at beginning of year | |||||||||||||||||||||||||||||||||||
charged to costs and expenses | |||||||||||||||||||||||||||||||||||
charged to other accounts | |||||||||||||||||||||||||||||||||||
deductions | |||||||||||||||||||||||||||||||||||
balance at end of year | |||||||||||||||||||||||||||||||||||
impairment of goodwill and other intangibles | |||||||||||||||||||||||||||||||||||
tax loss (benefit) related to vesting of restricted stock | 23,000 | -36,000 | 46,000 | ||||||||||||||||||||||||||||||||
costs and estimated profits in excess of billings on uncompleted contracts | 5,486,000 | -2,643,000 | -3,340,000 | ||||||||||||||||||||||||||||||||
billings in excess of costs and estimated profits on uncompleted contracts | -1,346,000 | 1,012,000 | -1,550,000 | ||||||||||||||||||||||||||||||||
sale of long-term investment | 0 | 3,376,000 | -1,688,000 | ||||||||||||||||||||||||||||||||
contributions from non-controlling interest owners | |||||||||||||||||||||||||||||||||||
net change in cash and cash equivalents | 6,649,000 | -921,000 | 2,362,000 | -2,170,000 | -38,000 | 6,662,000 | |||||||||||||||||||||||||||||
cash and cash equivalents at beginning of period | 0 | 0 | 47,000 | 0 | 0 | 5,469,000 | 0 | ||||||||||||||||||||||||||||
cash and cash equivalents at end of period | 6,649,000 | -921,000 | 2,409,000 | -2,170,000 | -38,000 | 12,131,000 | -3,823,000 | ||||||||||||||||||||||||||||
purchase of long-term investment | 0 | ||||||||||||||||||||||||||||||||||
increase in cash and cash equivalents |
We provide you with 20 years of cash flow statements for DXP Enterprises stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of DXP Enterprises stock. Explore the full financial landscape of DXP Enterprises stock with our expertly curated income statements.
The information provided in this report about DXP Enterprises stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.